-
Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.
Jan 29, 2024
-
Jan 16, 2024
-
Jan 15, 2024
-
Jan 19, 2024
-
Jan 23, 2024
-
CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.
Jan 28, 2024
-
Jan 24, 2024
-
Jan 24, 2024
-
ScyTek laboratories inc Biotech manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology, Hematoxlyn etc https://www.scytek.com
Jan 25, 2024
-
Jan 24, 2024
-
Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly.
Jan 16, 2024
-
Jan 23, 2024
-
Jan 23, 2024
-
Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.
Jan 23, 2024
-
Verisense Health combined its wearable technology expertise and clinical research knowledge to satisfy this unmet market need.
Jan 23, 2024
-
Johari Digital Healthcare appoints Mr. Suhas Tamras as CEO. With 25+ years in medical device leadership, his proven success aligns with JDHL's commitment to excellence. Excited about global impact, Mr. Tamras pledges growth and innovation, marking a new era for JDHL.
Jan 23, 2024
-
CD BioSciences announced the launch of Chromogenic Substrates for immunohistochemistry (IHC).
Jan 21, 2024
-
Jan 21, 2024
-
Jan 21, 2024
-
Creative Diagnostics has announced P53 and TP53 antibodies and solutions to support cancer research.
Jan 21, 2024